Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

BACKGROUND: The exact risk of developing QTc-prolongation when using a combination of QTc-prolonging drugs is still unknown, making it difficult to interpret these QT drug-drug interactions (QT-DDIs). A tool to identify high-risk patients is needed to support healthcare providers in handling automat...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Florine A., van der Sijs, Heleen, Becker, Matthijs L., van Gelder, Teun, van den Bemt, Patricia M. L. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376881/
https://www.ncbi.nlm.nih.gov/pubmed/32703198
http://dx.doi.org/10.1186/s12911-020-01181-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376881/
https://www.ncbi.nlm.nih.gov/pubmed/32703198
http://dx.doi.org/10.1186/s12911-020-01181-3

Ejemplares similares